Health Care·Pharmaceuticals·$2.8B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.14 | N/A | +32.87% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $1.14 | N/A | +32.87% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Overall, management expressed a positive outlook on product demand despite supply chain issues. They are focused on maintaining growth through innovation.
Management highlighted strong demand for key products.
They noted ongoing challenges in supply chain but remain focused on growth.
The team emphasized their commitment to innovation and market expansion.
Prestige Consumer HE's strong EPS performance, exceeding expectations by nearly 33%, contributed to a 6.19% increase in stock price. The positive reaction reflects investor confidence in the company's ability to navigate current market challenges. However, the lack of revenue data and guidance leaves some uncertainty about future performance.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
SIMON PPTY GROUP INC REIT
Aug 2, 2021